About: Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Latest price: $0.72 (-14.45%)
RGNT NYSE Regentis Biomaterials Ltd.
Regentis Biomaterials Ltd. share price
Atividade de preço de RGNT
Último preço
$ 0,720
Variação (24h)
-0,12 USD (14,42%)
Volume
122.34K
Volume (média 4 sem.)
-
Abertura
$ 0,88
Variação do dia
$ 0,71 - $ 0,89
Fechamento anterior
$ 0,84
Último negócio
20 Nov, 8:59 pm GMT+0
Atrasado
20 Nov, 8:59 pm GMT+0
RGNT price performance
Atrasado
20 Nov, 8:59 pm GMT+0
RGNT details
quote.marketSignals